Seeing Machines excites investors as it benefits from driver monitoring legislation Watch Now

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price: 1,718.20
Bid: 1,715.20
Ask: 1,716.20
Change: 0.00 (0.00%)
Spread: 1.00 (0.06%)
Open: 1,731.60
High: 1,737.40
Low: 1,703.20
Yest. Close: 1,737.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

UPDATE 1-GSK recalls popular heartburn medicine Zantac - U.K. medicines watchdog

Tue, 8th Oct 2019 16:53

(Adds context on U.S. FDA move)

Oct 8 (Reuters) - GlaxoSmithKline Plc is recalling
its heartburn medicine Zantac as a "precautionary measure" due
to a probable cancer-causing impurity in the drug, Britain's
medicines watchdog said on Tuesday.

The move follows the U.S. Food and Drug Administration
discovery last week of "unacceptable levels" of a cancer-causing
impurity in Zantac and its generic versions known chemically as
ranitidine.

GSK is recalling all unexpired stock of Zantac from
pharmacies due to possible contamination with an impurity
N-nitrosodimethylamine (NDMA), the Medicines and Healthcare
products Regulatory Agency (MHRA) said https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-zantac-injection-50mg-2ml-zantac-syrup-150mg-10ml-zantac-tablets-150mg-zantac-tablets-300mg-el-19-a-24.

The company was not immediately available for a comment.

U.S. and European health regulators said last month they
were reviewing the safety of ranitidine, after online pharmacy
Valisure flagged the impurities to regulators. Canada's health
authorities have also asked makers of the drug to halt
distribution as they gathers more information.

The FDA, which checked the over-the-counter drugs using a
low-heat method of testing, said it found much lower levels of
the impurity NDMA than was discovered with a higher temperature
test employed by Valisure.

For a related timeline:
(Reporting by Justin George Varghese in Bengaluru; editing by
Deepa Babington)

More News

Thursday broker round-up

(Sharecast News) - Associated British Foods: Goldman Sachs upgrades to buy with a target price of 2,750p.

7 Nov 19 13:28

Liberum hikes target price for GSK but stays at hold

(Sharecast News) - Analysts at Liberum hiked their target price for shares of GlaxoSmithKline after switching valuation methods given the company's medium-term plans to split its Consumer Health business from its Pharmaceuticals arm.

4 Nov 19 15:50

GlaxoSmithKline posts better-than-expected Q3 EPS, guides higher for the year

(Sharecast News) - GlaxoSmithKline shares advanced on Wednesday following the group's better-than-expected third quarter results and upwardly revised financial guidance for the year.

30 Oct 19 15:59

LIVE MARKETS-Banks battered on big earnings day

* European shares flat before Fed meeting * Fiat Chrysler and PSA confirm tie-up talks, stocks rally * Bank earnings in focus: DB, CS, StanChart, Santander * Fed seen cutting rates, focus on policy outlook Welcome to the home fo...

30 Oct 19 12:42

LIVE MARKETS-We're unlikely to see a repeat of late 2018 rout

* European shares flat before Fed meeting * Fiat Chrysler and PSA confirm tie-up talks, stocks rally * Bank earnings in focus: DB, CS, StanChart, Santander * Fed seen cutting rates, focus on policy outlook Welcome to the home fo...

30 Oct 19 11:44

RPT-Ex-FDA chief Gottlieb sees investment opportunity in 'unloved' antibiotics

(Repeats story from Tuesday with no changes to headline or text)By Rebecca SpaldingNEW YORK, Oct 29 (Reuters) - As a private investor, former U.S. Food and Drug Administration Commissioner Scott Gottlieb is focused on an area where few have found ...

30 Oct 19 11:00

UPDATE 2-Pharma stocks lift FTSE 100 out of red

* FTSE 100 up 0.3%, FTSE 250 down 0.3%* GSK, AstraZeneca among biggest boosts* Next Plc falls after Q3 update* Passport maker De La Rue hits lowest in two decades (Adds company news, updates share moves to close)By Muvija M and Shashwat AwasthiOct 3...

30 Oct 19 09:49

LIVE MARKETS-Opening snapshot: PSA and Fiat Chrysler steal the show

* European shares open little changed before Fed meeting * Fiat Chrysler and PSA confirm tie-up talks, stocks rally * Bank earnings in focus: DB, CS, StanChart, Santander * Fed seen cutting rates, focus on policy outlook Welcome...

30 Oct 19 08:29

LIVE MARKETS-On the radar: Corporate top news overload

* European shares seen opening little changed* Fiat Chrysler and PSA confirm tie-up talks* Bank earnings in focus: DB, CS, StanChart, Santander* Federal Reserve seen cutting rates, focus on policy outlook Welcome to the home for real-time coverage o...

30 Oct 19 07:37

LIVE MARKETS-Fed watching, Q3 galore and the Xmas Brexit election

Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters and anchored today by Julien Ponthus. Reach him on Messenger to share your thoughts on market moves: julien.ponthus.thomsonreuters.com@...

30 Oct 19 06:45

Ex-FDA chief Gottlieb sees investment opportunity in 'unloved' antibiotics

By Rebecca SpaldingNEW YORK, Oct 29 (Reuters) - As a private investor, former U.S. Food and Drug Administration Commissioner Scott Gottlieb is focused on an area where few have found success in recent years: developing new antibiotics.Since leavin...

29 Oct 19 21:26

Wednesday preview: Vote in Parliament, GlaxoSmithKline in focus

(Sharecast News) - The market spotlight on Wednesday will continue to be very much on Brexit, with investors keen to find out what Parliament voted the night before regarding the timing of the upcoming general elections.

29 Oct 19 15:24

UPDATE 2-FTSE 100 ekes out gains on pharma strength

* FTSE 100 up 0.1%, FTSE 250 up 0.5%* Astra, GSK offer most support to main bourse* HSBC falls after profit miss* Cairn Energy biggest midcap faller (Adds company news items, changes analyst quote, updates share moves)By Muvija M and Shashwat Awast...

28 Oct 19 09:17

UPDATE 1-FDA investigating whether Zantac causes carcinogens to form in users

(Adds details)NEW YORK, Oct 24 (Reuters) - The U.S. Food and Drug Administration is investigating whether the popular heartburn drug Zantac causes carcinogens to form in the bodies of users, in an effort to fully understand the risks posed by the ...

24 Oct 19 22:38

FDA investigating whether Zantac causes carcinogens to form in patients’ bodies

NEW YORK, Oct 24 (Reuters) - The U.S. Food and Drug Administration is investigating whether the popular heartburn drug Zantac causes carcinogens to form in the bodies of patients in an effort to fully understand the risks posed by the already rec...

24 Oct 19 22:05

Login to your account

Don't have an account? Click here to register.